somac 20 mg
orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 20 mg
somac 40 mg
orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 40 mg
somac 40 mg
orifarm as - pantoprazolnatriumsesquihydrat - pulver til injeksjonsvæske, oppløsning - 40 mg
adempas
bayer ag - riociguat - hypertensjon, pulmonal - antihypertensive midler for pulmonal arteriell hypertensjon - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. effekten har vært vist i en pah befolkningen, herunder aetiologies av idiopatisk eller heritable pah eller pah assosiert med bindevev sykdom. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.
allopurinol orion 300 mg
orion corporation - espoo - allopurinol - tablett - 300 mg
allopurinol orion 100 mg
orion corporation - espoo - allopurinol - tablett - 100 mg
escitalopram sanoswiss 10 mg
sanoswiss uab - escitalopramoksalat - tablett, filmdrasjert - 10 mg
escitalopram sanoswiss 5 mg
sanoswiss uab - escitalopramoksalat - tablett, filmdrasjert - 5 mg
adempas 0.5 mg
abacus medicine a/s - riociguat - tablett, filmdrasjert - 0.5 mg
adempas 1 mg
abacus medicine a/s - riociguat - tablett, filmdrasjert - 1 mg